Has Jose Cardona received payments from drug or device companies?

Yes. Drug and device makers reported $14,931 in general payments to Jose Cardona across 94 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jose Cardona did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jose Cardona come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jose Cardona

General Practice · Miami, FLNPI 1932107695

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Merck at 28.1% of the total. Reporting peaked in 2023 at $4,372 and has fallen 69.5% since, to $1,333 in 2025. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,931in general payments, 2019–2025

Across 94 payments — averaging $158.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$4K
Radius Health, Inc.$4K
Modernatx, Inc.$3K
Bayer$1K
Amgen$1K
Eli Lilly$1K
plus $191 from 3 others

$71,136,021in research payments, 2019–2025

Across 3,001 payments — averaging $23,704 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Modernatx, Inc.$21.7M
Pfizer$20.1M
Merck$6.3M
Eli Lilly$3.7M
AstraZeneca$2.9M
Janssen Research & Development, LLC$2.2M
plus $14.1M from 31 others

What the payments were for

Consulting fees$1,0007%
Speaking & faculty fees$9436%
Travel & lodging$8,41156%
Food & beverage$3,39923%
Education$1,1598%
Gifts$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	34	$4,196
Radius Health, Inc.	21	$3,750
Modernatx, Inc.	15	$3,127
Bayer	10	$1,292
Amgen	5	$1,270
Eli Lilly	6	$1,106
Boston Scientific	1	$131
Merz North America, Inc.	1	$40
Pfizer	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

V114$2,270
Tymlos$2,047
LAGEVRIO$1,023
GENERAL - THERAPIES$131

How this compares

$14,931 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Other general practice in Miami

Idalia AcostaMiami$99K
Eddie GomezMiami$59K
Aladino ValienteMiami$24K
Viviana WaichMiami$20K
Libia RiosMiami$15K
Rosa HuguetMiami$15K
Robert VogelPalm Beach Gardens$1M
Bruce OuelletteWest Palm Beach$724K
Caley CasteleinMiami Beach$586K
Sarah JockinTampa$308K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →